company
as of 2026-07-01Kynexis B.V.
at a glance
2 trials sponsored · 4 assets in the graph
Synthesized from structured facts only — each point cited above.
Financials
SEC EDGAR XBRL · latest period per metric
No financials loaded for this company (may be non-US-listed — recorded as a gap, not faked).
Pipeline
4 assets
Facts & assertions
0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
asset
KYN-5356
drugsmall molecule
KYN-5356 High Dose
drugsmall molecule
KYN-5356 Medium Dose
drugsmall molecule
KYN-5356 low dose
drugsmall molecule